Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized, Open-label, Active-controlled, Parallel-group, Multicenter Study to Investigate the Efficacy and Safety of Oral Molidustat in Comparison to Darbepoetin Alfa in Non-dialysis Subjects With Renal Anemia Who Are Not Treated With Erythropoiesis-Stimulating Agents (ESAs)
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of molidustat in non-dialysis subjects with renal anemia who are not treated with Erythropoiesis-Stimulating Agents (ESAs).


Options:
A: Arm Label: AKB-6548 240 mg; Type: EXPERIMENTAL; Interventions: Drug: AKB-6548 | Arm Label: AKB-6548 370 mg; Type: EXPERIMENTAL; Interventions: Drug: AKB-6548 | Arm Label: AKB-6548 500 mg; Type: EXPERIMENTAL; Interventions: Drug: AKB-6548 | Arm Label: AKB-6548 630 mg; Type: EXPERIMENTAL; Interventions: Drug: AKB-6548 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: AKB-6548; Assigned to Arm(s): AKB-6548 240 mg, AKB-6548 370 mg, AKB-6548 500 mg, AKB-6548 630 mg | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Roxadustat 0.7 mg/kg BIW; Type: EXPERIMENTAL; Interventions: Drug: Roxadustat | Arm Label: Roxadustat 0.7 mg/kg TIW; Type: EXPERIMENTAL; Interventions: Drug: Roxadustat | Arm Label: Roxadustat 1.0 mg/kg BIW; Type: EXPERIMENTAL; Interventions: Drug: Roxadustat | Arm Label: Roxadustat 1.0 mg/kg TIW; Type: EXPERIMENTAL; Interventions: Drug: Roxadustat | Arm Label: Roxadustat 1.5 mg/kg BIW; Type: EXPERIMENTAL; Interventions: Drug: Roxadustat | Arm Label: Roxadustat 1.5 mg/kg TIW; Type: EXPERIMENTAL; Interventions: Drug: Roxadustat | Arm Label: Roxadustat 2.0 mg/kg BIW; Type: EXPERIMENTAL; Interventions: Drug: Roxadustat | Arm Label: Roxadustat 2.0 mg/kg TIW; Type: EXPERIMENTAL; Interventions: Drug: Roxadustat | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Roxadustat; Assigned to Arm(s): Roxadustat 0.7 mg/kg BIW, Roxadustat 0.7 mg/kg TIW, Roxadustat 1.0 mg/kg BIW, Roxadustat 1.0 mg/kg TIW, Roxadustat 1.5 mg/kg BIW, Roxadustat 1.5 mg/kg TIW, Roxadustat 2.0 mg/kg BIW, Roxadustat 2.0 mg/kg TIW | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: BAY85-3934 (25mg OD); Type: EXPERIMENTAL; Interventions: Drug: BAY85-3934, Drug: Placebo | Arm Label: BAY85-3934 (50mg OD); Type: EXPERIMENTAL; Interventions: Drug: BAY85-3934, Drug: Placebo | Arm Label: BAY85-3934 (75mg OD); Type: EXPERIMENTAL; Interventions: Drug: BAY85-3934, Drug: Placebo | Arm Label: BAY85-3934 (25mg BID); Type: EXPERIMENTAL; Interventions: Drug: BAY85-3934, Drug: Placebo | Arm Label: BAY85-3934 (50mg BID); Type: EXPERIMENTAL; Interventions: Drug: BAY85-3934, Drug: Placebo | Arm Label: Placebo BID; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: BAY85-3934; Assigned to Arm(s): BAY85-3934 (25mg BID), BAY85-3934 (25mg OD), BAY85-3934 (50mg BID), BAY85-3934 (50mg OD), BAY85-3934 (75mg OD) | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): BAY85-3934 (25mg BID), BAY85-3934 (25mg OD), BAY85-3934 (50mg BID), BAY85-3934 (50mg OD), BAY85-3934 (75mg OD), Placebo BID
D: Arm Label: Molidustat (BAY85-3934); Type: EXPERIMENTAL; Interventions: Drug: Molidustat (BAY85-3934) | Arm Label: Darbepoetin alfa; Type: ACTIVE_COMPARATOR; Interventions: Drug: Darbepoetin alfa | Intervention Type: DRUG; Name: Molidustat (BAY85-3934); Assigned to Arm(s): Molidustat (BAY85-3934) | Intervention Type: DRUG; Name: Darbepoetin alfa; Assigned to Arm(s): Darbepoetin alfa

Answer: D